David Low
Stock Analyst at UBS
(3.66)
# 2,129
Out of 5,078 analysts
315
Total ratings
51.1%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $26.00 | $13.19 | +97.12% | 9 | Oct 22, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | n/a | $35.91 | - | 26 | Oct 20, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $135.00 | $146.81 | -8.04% | 24 | Oct 19, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $38.70 | $46.27 | -16.36% | 18 | Oct 4, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $21.20 | $18.89 | +12.23% | 34 | Sep 23, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $181.00 | $196.70 | -7.98% | 32 | Sep 2, 2026 | |
| ASX: REG Regis Healthcare Limited | Reiterated: Hold | $6.75 → $5.95 | $4.78 | +24.48% | 16 | Sep 2, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $42.90 → $55.60 | $54.79 | +1.48% | 21 | Aug 28, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.25 → $3.40 | $2.09 | n/a | 12 | Aug 27, 2025 | |
| ASX: NAN Nanosonics Limited | Reiterated: Sell | $4.00 → $3.90 | $3.04 | n/a | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.30 | $0.88 | n/a | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47.02 → $44.58 | $20.65 | n/a | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.62 | $0.44 | n/a | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $282.00 → $300.00 | $198.38 | n/a | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $310 | $252.86 | n/a | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32.00 → $35.00 | $48.87 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.95 → $0.78 | $0.24 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.21 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $34.60 | n/a | 1 | Dec 4, 2019 |
Telix Pharmaceuticals Limited
Oct 22, 2026
Reiterated: Buy
Price Target: $26.00
Current: $13.19
Upside: +97.12%
ResMed Inc.
Oct 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.91
Upside: -
Cochlear Limited
Oct 19, 2026
Reiterated: Hold
Price Target: $135.00
Current: $146.81
Upside: -8.04%
Ansell Limited
Oct 4, 2026
Reiterated: Hold
Price Target: $38.70
Current: $46.27
Upside: -16.36%
Sonic Healthcare Limited
Sep 23, 2026
Reiterated: Hold
Price Target: $21.20
Current: $18.89
Upside: +12.23%
CSL Limited
Sep 2, 2026
Reiterated: Buy
Price Target: $181.00
Current: $196.70
Upside: -7.98%
Regis Healthcare Limited
Sep 2, 2026
Reiterated: Hold
Price Target: $6.75 → $5.95
Current: $4.78
Upside: +24.48%
Ramsay Health Care Limited
Aug 28, 2026
Reiterated: Hold
Price Target: $42.90 → $55.60
Current: $54.79
Upside: +1.48%
Integral Diagnostics Limited
Aug 27, 2025
Reiterated: Buy
Price Target: $3.25 → $3.40
Current: $2.09
Upside: n/a
Nanosonics Limited
Aug 27, 2025
Reiterated: Sell
Price Target: $4.00 → $3.90
Current: $3.04
Upside: n/a
Aug 27, 2025
Reiterated: Hold
Price Target: $1.30
Current: $0.88
Upside: n/a
Aug 27, 2025
Reiterated: Hold
Price Target: $47.02 → $44.58
Current: $20.65
Upside: n/a
Aug 25, 2025
Reiterated: Sell
Price Target: $0.62
Current: $0.44
Upside: n/a
Aug 14, 2025
Reiterated: Hold
Price Target: $282.00 → $300.00
Current: $198.38
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $290 → $310
Current: $252.86
Upside: n/a
Jun 3, 2025
Reiterated: Hold
Price Target: $32.00 → $35.00
Current: $48.87
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $0.95 → $0.78
Current: $0.24
Upside: n/a
Aug 23, 2021
Reiterated: Hold
Price Target: n/a
Current: $13.21
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $34.60
Upside: n/a